Long-term Follow-up Outcome of Patients Undergoing Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma
β Scribed by Junji Machi; Racquel S. Bueno; Linda L. Wong
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 117 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Potentially curative radical pancreaticoduodenectomy for ampullary adenocarcinoma was performed in 24 patients over a 35-year period. The overall operative mortality was 12.5%. Actuarial survival rate at 5 years was 61% f 13.4 standard error of the mean (SEM) and subsequently remained unchanged. In
In most patients with cirrhosis, successful percutaneous ablation or surgical resection of hepatocellular carcinoma (HCC) is followed by recurrence. Radiofrequency ablation (RFA) has proven effective for treating HCC nodules, but its repeatability in managing recurrences and the impact of this appro
For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is in some centers considered a first-line therapeutic option. However, such a strategy is still under debate with regard to tumor and patient characteristics. In this single-center study we assessed the 5-year